Use of lantibiotic synthetases for the preparation of bioactive constrained peptides

被引:37
作者
Levengood, Matthew R. [1 ]
van der Donk, Wilfred A. [1 ]
机构
[1] Univ Illinois, Dept Chem, Urbana, IL 61801 USA
关键词
cyclic peptides; enkephalin; conotoxin; lantibiotic; dehydroalanine;
D O I
10.1016/j.bmcl.2008.01.062
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Stabilization of biologically active peptides is a major goal in peptide-based drug design. Cyclization is an often-used strategy to enhance resistance of peptides toward protease degradation and simultaneously improve their affinity for targets by restricting their conformational flexibility. Among the various cyclization strategies, the use of thioether crosslinks has been successful for various peptides including enkephalin. The synthesis of these thioethers can be arduous, especially for longer peptides. Described herein is an enzymatic strategy taking advantage of the lantibiotic synthetase LctM that dehydrates Ser and Thr residues to the corresponding dehydroalanine and dehydrobutyrine residues and catalyzes the Michael-type addition of Cys residues to form thioether crosslinks. The use of LctM to prepare thioether containing analogs of enkephalin, contryphan, and inhibitors of human tripeptidyl peptidase II and spider venom epimerase is demonstrated. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3025 / 3028
页数:4
相关论文
共 40 条
[1]   α-selenoconotoxins, a new class of potent α7 neuronal nicotinic receptor antagonists [J].
Armishaw, Christopher J. ;
Daly, Norelle L. ;
Nevin, Simon T. ;
Adams, David J. ;
Craik, David J. ;
Alewood, Paul F. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (20) :14136-14143
[2]   Solid-phase synthesis and biological activity of a thioether analogue of conotoxin G1 [J].
Bondebjerg, J ;
Grunnet, M ;
Jespersen, T ;
Meldal, M .
CHEMBIOCHEM, 2003, 4 (2-3) :186-194
[3]   Orthogonally protected lanthionines: Synthesis and use for the solid-phase synthesis of an analogue of nisin ring C [J].
Bregant, S ;
Tabor, AB .
JOURNAL OF ORGANIC CHEMISTRY, 2005, 70 (07) :2430-2438
[4]  
Burrage S, 2000, CHEM-EUR J, V6, P1455, DOI 10.1002/(SICI)1521-3765(20000417)6:8<1455::AID-CHEM1455>3.3.CO
[5]  
2-D
[6]   Biosynthesis and mode of action of lantibiotics [J].
Chatterjee, C ;
Paul, M ;
Xie, LL ;
van der Donk, WA .
CHEMICAL REVIEWS, 2005, 105 (02) :633-683
[7]   Lacticin 481 synthetase phosphorylates its substrate during lantibiotic production [J].
Chatterjee, C ;
Miller, LM ;
Leung, YL ;
Xie, LL ;
Yi, MS ;
Kelleher, NL ;
van der Donk, WA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (44) :15332-15333
[8]   Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase [J].
Chatterjee, Champak ;
Patton, Gregory C. ;
Cooper, Lisa ;
Paul, Moushumi ;
van der Donk, Wilfred A. .
CHEMISTRY & BIOLOGY, 2006, 13 (10) :1109-1117
[9]   A concise stereoselective synthesis of orthogonally protected lanthionine and β-methyllanthionine [J].
Cobb, Steven L. ;
Vederas, John C. .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2007, 5 (07) :1031-1038
[10]   Chemical modification of conotoxins to improve stability and activity [J].
Craik, David J. ;
Adams, David J. .
ACS CHEMICAL BIOLOGY, 2007, 2 (07) :457-468